Anti-Microbialvior BioteQ Co (ROCO:6864) COGS-to-Revenue : 1.10 (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Anti-Microbialvior BioteQ Co COGS-to-Revenue?

Anti-Microbialvior BioteQ Co's Cost of Goods Sold for the six months ended in Dec. 2024 was NT$0.29 Mil. Its Revenue for the six months ended in Dec. 2024 was NT$0.27 Mil.

Anti-Microbialvior BioteQ Co's COGS to Revenue for the six months ended in Dec. 2024 was 1.10.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Anti-Microbialvior BioteQ Co's Gross Margin % for the six months ended in Dec. 2024 was -10.11%.

Anti-Microbialvior BioteQ Co COGS-to-Revenue Historical Data

The historical data trend for Anti-Microbialvior BioteQ Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anti-Microbialvior BioteQ Co COGS-to-Revenue Chart

Anti-Microbialvior BioteQ Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

COGS-to-Revenue

Get a 7-Day Free Trial

0.03

0.47

0.52

0.55

0.76

Anti-Microbialvior BioteQ Co Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
COGS-to-Revenue	Get a 7-Day Free Trial							0.55	0.55	0.53	0.50	1.10

Anti-Microbialvior BioteQ Co COGS-to-Revenue Calculation

Anti-Microbialvior BioteQ Co's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.468	/	0.612
	=	0.76

Anti-Microbialvior BioteQ Co's COGS to Revenue for the quarter that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.294	/	0.267
	=	1.10

Anti-Microbialvior BioteQ Co (ROCO:6864) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Anti-Microbialvior BioteQ Co's Gross Margin % for the six months ended in Dec. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.294 / 0.267
	=	-10.11 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Anti-Microbialvior BioteQ Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Anti-Microbialvior BioteQ Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Anti-Microbialvior BioteQ Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anti-Microbial Savior BioteQ Co Ltd (ROCO:6864) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 6, Siwei 3rd Road, 7th Floor-2, Lingya District, Kaohsiung, TWN, 741

Website

https://www.ams-bioteq.com

Anti-Microbial Savior BioteQ Co Ltd is engaged in drug research and development as well as development and technology patenting of medical fungi.

Anti-Microbialvior BioteQ Co Headlines

No Headlines